David Baltimore's Net Worth

$15.3 Million

Estimate Recalculated Jun 4, 2024 06:34PM EST

Who is David Baltimore?

David Baltimore has an estimated net worth of $15.3 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., Regulus Therapeutics Inc., AMGEN INC, and MEDIMMUNE INC /DE.

SEC CIK

David Baltimore's CIK is 0001185858

Past Insider Trading and Trends

2018 was David Baltimore's most active year for acquiring shares with 5 total transactions. David Baltimore's most active month to acquire stocks was the month of March. 2018 was David Baltimore's most active year for disposing of shares, totalling 17 transactions. David Baltimore's most active month to dispose stocks was the month of October. 2011 saw David Baltimore paying a total of $1,174,250.00 for 22,828 shares, this is the most they've acquired in one year. In 2005 David Baltimore cashed out on 60,000 shares for a total of $3,388,164.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMMUNE DESIGN CORP. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-78.29K
$5.85
-$457,978.95
0
Apr 2
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 7
Form 3
—
0
—
—
0
No matching records found

Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.4

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
Aug 10
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Oct 10
Form 4
+1,063.79%
40.34K
—
—
44.13K
Nov 12
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
May 17
Form 4
∞
60.67K
$0.89
$53,999.86
60.67K
Dec 4
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
Jun 10
Form 3
—
0
—
—
0
No matching records found

AMGEN INC (AMGN) Snapshot price: $297.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.62%
1.13K
—
—
32.29K
Apr 27
Form 4
-10.61%
-3.70K
$153.93
-$569,541.00
31.16K
May 31
Form 4
+3.66%
1.23K
—
—
34.86K
May 1
Form 4
+3.95%
1.28K
—
—
33.63K
May 3
Form 4
-9.29%
-3.31K
$157.21
-$520,683.83
32.35K
Apr 29
Form 4
+10.24%
3.31K
$99.97
-$139.12
35.66K
Mar 30
Form 4
+3.82%
1.19K
—
—
32.35K
Apr 24
Form 4
-10.48%
-3.65K
$158.76
-$579,011.21
31.16K
Mar 2
Form 4
+11.70%
3.65K
$98.96
-$120.34
34.81K
Feb 19
Form 4
+6.11%
1.79K
—
—
31.16K
Apr 25
Form 4
+9.25%
2.48K
$93.46
-$15.40
29.36K
Feb 26
Form 4
-16.97%
-5.49K
$109.66
-$502,462.12
26.88K
Aug 28 - Aug 29
Form 4
+6.04%
1.84K
—
—
32.37K
Apr 26
Form 4
—
0
$83.13
-$82,392.26
30.53K
Feb 28
Form 4
—
0
$69.69
-$605,284.40
30.53K
Dec 10
Form 4
+4.79%
1.4K
—
—
30.53K
Apr 27
Form 4
+2.18%
622
$62.78
-$57.10
29.13K
Mar 8
Form 4
+6.47%
1.73K
$59.72
-$18.38
28.51K
Dec 22
Form 4
+7.33%
1.83K
—
—
26.78K
Apr 25
Form 4
+7.36%
1.71K
—
—
24.95K
Apr 26
Form 4
∞
1.98K
—
—
1.98K
Apr 28
Form 4
-49.70%
-21.00K
$57.37
-$1,204,748.97
21.25K
Dec 5
Form 4
+244.80%
30K
$29.97
$899,064.00
42.26K
Dec 3
Form 4
+24.01%
2.37K
—
—
12.26K
Apr 29
Form 4
+19.29%
1.6K
—
—
9.88K
Apr 26
Form 4
+19.21%
1.33K
—
—
8.28K
Mar 15
Form 4
—
0
$56.47
-$1,590,036.00
6.95K
Nov 18
Form 4
∞
1.71K
—
—
1.71K
Mar 15
Form 4
∞
1.64K
—
—
1.64K
Mar 15
No matching records found

MEDIMMUNE INC /DE No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.56K
—
—
0
Jun 18
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Aug 14
Form 3
—
0
—
—
0
No matching records found